Source: ALL
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 28
Gene Symbol: ABO
ABO
0.010 Biomarker phenotype BEFREE Evidence for an association between ABO blood group and goitre. 939553 1976
Entrez Id: 91
Gene Symbol: ACVR1B
ACVR1B
0.010 AlteredExpression phenotype BEFREE Semi-quantitative RT-PCR revealed a significant 2.5-fold decrease of mRNA for alk4-1 type I activin receptors in goiter as compared to normal thyroid (p < 0.05), whereas expression of the type II receptor actRII was unchanged. 11069203 2000
Entrez Id: 92
Gene Symbol: ACVR2A
ACVR2A
0.010 AlteredExpression phenotype BEFREE Semi-quantitative RT-PCR revealed a significant 2.5-fold decrease of mRNA for alk4-1 type I activin receptors in goiter as compared to normal thyroid (p < 0.05), whereas expression of the type II receptor actRII was unchanged. 11069203 2000
Entrez Id: 207
Gene Symbol: AKT1
AKT1
0.100 Biomarker phenotype HPO
Entrez Id: 213
Gene Symbol: ALB
ALB
0.010 GeneticVariation phenotype BEFREE Thyroid tissue total RNAs from multinodular goiter (G2) and from hereditary goiter with defective Tg synthesis (JNA) were hybridized with a 5'albumin cDNA probe (F-47), a 3' albumin cDNA probe (B-44) and a thyroglobulin cDNA probe (phTgM3). 8370916 1993
Entrez Id: 250
Gene Symbol: ALPP
ALPP
0.010 Biomarker phenotype BEFREE In addition, dietary RSM inclusion levels induced liver enlargement in ducklings at day 21 (5 to 20% double-low RSM with 1.37 to 5.31 µmol/g GLS) and thyroid enlargement accompanied by increased serum AST and ALP activities in ducks at day 42 (5 to 15% Indian RSM with 7.67 to 23.66 µmol/g GLS). 31347686 2019
Entrez Id: 284
Gene Symbol: ANGPT1
ANGPT1
0.010 AlteredExpression phenotype BEFREE In an induced goiter in rats, in situ hybridization showed increased expression of messenger ribonucleic acids (mRNAs) for Tie-2 and Ang-1 in follicular cells. 11397875 2001
Entrez Id: 80150
Gene Symbol: ASRGL1
ASRGL1
0.010 Biomarker phenotype BEFREE In addition, dietary RSM inclusion levels induced liver enlargement in ducklings at day 21 (5 to 20% double-low RSM with 1.37 to 5.31 µmol/g GLS) and thyroid enlargement accompanied by increased serum AST and ALP activities in ducks at day 42 (5 to 15% Indian RSM with 7.67 to 23.66 µmol/g GLS). 31347686 2019
Entrez Id: 470
Gene Symbol: ATHS
ATHS
0.010 Biomarker phenotype BEFREE In addition, dietary RSM inclusion levels induced liver enlargement in ducklings at day 21 (5 to 20% double-low RSM with 1.37 to 5.31 µmol/g GLS) and thyroid enlargement accompanied by increased serum AST and ALP activities in ducks at day 42 (5 to 15% Indian RSM with 7.67 to 23.66 µmol/g GLS). 31347686 2019
Entrez Id: 26033
Gene Symbol: ATRNL1
ATRNL1
0.010 Biomarker phenotype BEFREE In addition, dietary RSM inclusion levels induced liver enlargement in ducklings at day 21 (5 to 20% double-low RSM with 1.37 to 5.31 µmol/g GLS) and thyroid enlargement accompanied by increased serum AST and ALP activities in ducks at day 42 (5 to 15% Indian RSM with 7.67 to 23.66 µmol/g GLS). 31347686 2019
Entrez Id: 581
Gene Symbol: BAX
BAX
0.010 AlteredExpression phenotype BEFREE Surprisingly, we observed elevated BAX levels in patients with thyroid carcinomas compared with patients with adenomas (unpaired t-test: p<0.05) or with goitres (p<0.02). 11351299 2001
Entrez Id: 673
Gene Symbol: BRAF
BRAF
0.020 Biomarker phenotype BEFREE All of the goiters had a wild-type BRAF status. 22181337 2012
Entrez Id: 673
Gene Symbol: BRAF
BRAF
0.020 GeneticVariation phenotype BEFREE The analysis of 130 aspirated samples from thyroid tumors (18 follicular adenomas, 72 papillary carcinomas [PTCs], 8 follicular carcinomas, 2 undifferentiated carcinomas, 1 medullary carcinoma, 2 malignant lymphomas, and 27 adenomatous goiters) revealed BRAF(T1796A) mutations in 37 (51.4%) of 72 PTCs, supporting the usefulness of this method. 15671769 2004
Entrez Id: 779
Gene Symbol: CACNA1S
CACNA1S
0.100 Biomarker phenotype HPO
Entrez Id: 790
Gene Symbol: CAD
CAD
0.010 Biomarker phenotype BEFREE Immunohistochemistry for CD56, HBME-1, COX-2, Ki-67, p53 and E-cadherin (E-CAD) was performed in 113 benign and 35 malignant thyroid lesions including 36 follicular adenomas (FA), 77 colloid goitres, 26 papillary thyroid carcinomas (PTC) and 9 follicular carcinomas (FC). 20640858 2010
Entrez Id: 796
Gene Symbol: CALCA
CALCA
0.010 AlteredExpression phenotype BEFREE MEN 2B was suspected owing to characteristic multiple ganglioneuromatosis when the patient presented with a goiter associated with high levels of plasma calcitonin and CEA. 11720239 2001
Entrez Id: 8030
Gene Symbol: CCDC6
CCDC6
0.030 Biomarker phenotype BEFREE The resulting areas under the receiver operating characteristic (ROC) curve were 0.78 for MGMT (d) for PTC versus goiter samples that can represent the overall ability of MGMT (d) methylation status to discriminate between PTC and goiter patients. 31127647 2019
Entrez Id: 8030
Gene Symbol: CCDC6
CCDC6
0.030 Biomarker phenotype BEFREE The expression of CD82 and CD63 was analysed by reverse transcriptase-PCR (RT-PCR) and immunohistochemistry in benign goiter (n=12) and 75 primary thyroid carcinoma tissue specimens (PTC: 33, FTC: 24, UTC: 18) out of which 36 were non-metastasized primary tumors and 39 were metastasized tumors (regional lymph node and/or distant metastases). 15375577 2004
Entrez Id: 8030
Gene Symbol: CCDC6
CCDC6
0.030 Biomarker phenotype BEFREE To achieve these goals, we determined the frequency of occult PTC among patients operated for MTC (n = 82) or undergoing total thyroidectomy mainly for goiter and/or nodules (n = 7313) between 1994-2001. 15588381 2004
Entrez Id: 10850
Gene Symbol: CCL27
CCL27
0.010 Biomarker phenotype BEFREE In addition, dietary RSM inclusion levels induced liver enlargement in ducklings at day 21 (5 to 20% double-low RSM with 1.37 to 5.31 µmol/g GLS) and thyroid enlargement accompanied by increased serum AST and ALP activities in ducks at day 42 (5 to 15% Indian RSM with 7.67 to 23.66 µmol/g GLS). 31347686 2019
Entrez Id: 595
Gene Symbol: CCND1
CCND1
0.010 AlteredExpression phenotype BEFREE We used real-time quantitative polymerase chain reaction (PCR) assays based on fluorescent TaqMan methodology to quantify MYC, ERBB2, and CCND1 gene amplification and expression in 24 benign tumors (adenomas and goiter nodules) and 12 carcinomas (9 papillary, 2 follicular, and 1 anaplastic) of the thyroid. 11288983 2001
Entrez Id: 967
Gene Symbol: CD63
CD63
0.010 AlteredExpression phenotype BEFREE The expression of CD82 and CD63 was analysed by reverse transcriptase-PCR (RT-PCR) and immunohistochemistry in benign goiter (n=12) and 75 primary thyroid carcinoma tissue specimens (PTC: 33, FTC: 24, UTC: 18) out of which 36 were non-metastasized primary tumors and 39 were metastasized tumors (regional lymph node and/or distant metastases). 15375577 2004
Entrez Id: 3732
Gene Symbol: CD82
CD82
0.010 AlteredExpression phenotype BEFREE All of the benign goiter tissues showed CD82 expression. 15375577 2004
Entrez Id: 64072
Gene Symbol: CDH23
CDH23
0.100 Biomarker phenotype HPO
Entrez Id: 1027
Gene Symbol: CDKN1B
CDKN1B
0.010 Biomarker phenotype BEFREE In papillary carcinomas, P27(KIP1) is preferentially cytoplasmic as opposed to goiter or normal thyroid tissue, where P27(KIP1) is preferentially located in the nucleus. 16051032 2005